Skip to content

Certifications, awards and grants

Biosfer Teslab has obtained many awards and grants through the years

Grants and Financial Resource​s

torres quevedo

Torres Quevedo Fellowship

2014, 2016, 2020 & 2021

Funded projects:

2021: Development of a diagnostic test for colorectal cancer based on metabolomics by Nuclear Magnetic Resonance. 

2020: Diagnostic metabolomics, uncovering the molecular fingerprint of cardio-metabolic disease 

2016: Design and automation of a lipidomic analysis by 1H-NMR for the estimation of cardiometabolic risk. 

2014:Design and development of an in vitro diagnostic test for improved cardiovascular risk assessment. 

grant - cdti pid

CDTI IDI

2020

India Bilateral Call –  Companion diagnostic for Sarogrlitazar, advancing cardiometabolic health: metabolomics for machine learning-based diagnostics.

agaur grant logo

AGAUR - Pandèmies 2020

2020

Biosfer Teslab participates as CO-IP together with Dr. Xavier Correig, head of the metabolomics platform of the Instituto de Investigación Sanitaria Pere Virgili IISPV.
Project – VISIONING: covid-19 prognosis tool, an affordable metabolomic artificial Intelligence-assisted blood testing analysis.

grant - Xpande digital logo

Xpande Digital

2020

“Biosfer Teslab has been a beneficiary of the European Regional Development Fund whose objective is to improve the use and quality of information and communication technologies and access to them and thanks to which it has implemented a communication strategy for the company for commercial purposes, to improve economic and social growth, to increase the positive perception among its current and future collaborators. January 2021. For this, it has had the support of the digital Xpande of the Reus Chamber of Commerce.”
A way to make Europe

grant - innowide

INNOWWIDE - H2020

2019

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement Nº 822273.

grant - cdti pid

CDTI PiD

2018

BIOSFER TESLAB, SL supported by CDTI under the PID Programme is implementing the Development of a prediction test for cardiometabolic disease, based on the advanced molecular profile using Nuclear Magnetic Resonance (NMR) spectroscopy and machine learnig techniques.

grant - cdti neotec

CDTI Neotec

2017

BIOSFER TESLAB, SL supported by CDTI under the NEOTEC Operational Programme is implementing the Development of new in vitro test based on Nuclear Magnetic Resonance (NMR) spectroscopy for an early detection of cardiometabolic diseases and cardiovascular diseases.

grant - doctorats industrials logo

Industrial Doctoral Plan Fellowship​

2016

Funded project: 1H-NMR glycoprotein analysis. An Advanced approach for inflammatory diseases diagnosis

grant - accio

Nuclis RD15-1-0013

2016

Biosfer Teslab, along the project, has developed a system of prediction, using of advanced prediction tests, with the aim to improve the evaluation of cardiovascular risk and to identify those individuals with residual cardiovascular risk that would remain undiagnosed with classical risk factors.

Enisa Funding

2015

Enisa is a public company – dependent to the Ministry of  Industry, Energy and Tourism, via the General Directorate of Industries and small and medium-sized enterprises – that, since 1982,  is also actively involved in the financing of innovative and viable business projects.

Certifications

aemps certification

AEMPS

The spanish agency of medicines and medical devices awards Biosfer Teslab with a license for software development.

innovate sme certification

Innovate SME

Ministry of the Economy, Industry and Competitiveness awards the company Biosfer Teslab as a certified innovate sme.

iso certificate

ISO 9001:2015

 Biosfer Teslab have the ISO 9001 Certification approved by TÜVRheinland.

sgs certification

ISO 13485:2016

Biosfer Teslab has the ISO 13485 Certification approved by SGS

Awards

tgn award logo

Innovation and Digitalization Award 2022 Tarragona

2022

To recognize the great work done by small and medium enterprises as generators of wealth and job creators in the performance of their daily work, Banco Santander, the Chamber of Commerce of Tarragona and the Chamber of Commerce of Reus convene, in collaboration with the Chamber of Spain and the newspaper La Vanguardia, the sixth edition of the SME of the Year Award Tarragona.

Alberto Elzaburu Foundation's Annual Innovation Award

Alberto Elzaburu Foundation's Annual Innovation Award

2019

The Alberto Elzaburu Foundation works in the service of intellectual and industrial property, a pillar on which progress and innovation gravitate. 

tgn open future logo

Tarragona Open Future

2019

The Tarragona Open Future program is aimed at entrepreneurs and companies that have a project related to the challenges proposed in each call and focuses on promoting projects and startups that can offer innovative and/or technology-based solutions.

big booster logo

Big Booster

2015

BigBooster helps high impact entrepreneurs accelerate their international strategy and better address their market(s) and connect & empower BigBooster community through a booster camp in Lyon, customized matchmaking and deep dive on local innovation ecosystems.

logo premis empren

Emprèn Awards

2014

The Emprèn Awards want to contribute to the recognition and visibility of the efforts of people and entrepreneurial initiatives that emerge in the territory.

reus empresa awards

Reus Business Creation Awards

2013

The Reus Business Creation Awards are open to all entrepreneurs in the Tarragona region with a business idea and, especially, to young people and students of the URV who are finishing their university studies. They aim to reward the two best business creation projects of the year of the call.

jci catalunya logo

Jove Cambra Internacional Catalunya

2013

The JCI Catalunya awarded Biosfer Teslab with the Award for Excellence in Medical Innovation

ACCIÓ GRANT

BIOSFER TESLAB, SL with the support of ACTION in the frame of the Operative Program FEDER Catalonia 2014-2020 has carried out the “DEVELOPMENT And VALIDATION OF ADVANCED DIAGNOSTIC TEST Of INFLAMMATION And  INSULIN RESISTANCE FOR THE IMPROVEMENT OF  CARDIOVASCULAR RISK USING NUCLEAR MAGNETIC RESONANCE”  (RD15-1-0013).

Biosfer Teslab, along the project, has developed a system of prediction, using of advanced prediction tests, with the aim to improve the evaluation of cardiovascular risk and to identify those individuals with residual cardiovascular risk that would remain undiagnosed with classical risk factors.

In particular, the company has developed a glycoprotein test and a LMWM test - that includes, branched amino acids -, as they have been identified as inflammatory markers and involved in insulin resistance processes, respectively.

The Agency for the Competitiveness of the Company, ACTION, aiding to industrial research centers and experimental development, has granted Biosfer Teslab with an amount of 67,728.97 €.

This aid is programmed in the axis 1, "Boost research, technological development and innovation", specific objective OE 1.2.2, "Transfer and spreading of technology and cooperation between companies and universities or other research centers", line of action "Collaborative R+D projects" under the framework of the FEDER Operational Program of Catalonia 2014-2020

INNOWIDE Grant

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement Nº 822273.

XPANDE Digital Grant

“Biosfer Teslab has been a beneficiary of the European Regional Development Fund whose objective is to improve the use and quality of information and communication technologies and access to them and thanks to which it has implemented a communication strategy for the company for commercial purposes, to improve economic and social growth, to increase the positive perception among its current and future collaborators. January 2021. For this, it has had the support of the digital Xpande of the Reus Chamber of Commerce.”
A way to make Europe

ENISA Funding

Enisa is a public company – dependent to the Ministry of  Industry, Energy and Tourism, via the General Directorate of Industries and small and medium-sized enterprises – that, since 1982,  is also actively involved in the financing of innovative and viable business projects.

CDTI GRANTS

Biosfer Teslab has received two different CDTI grants

BIOSFER TESLAB, SL supported by CDTI under the NEOTEC Operational Programme is implementing the Development of new in vitro test based on Nuclear Magnetic Resonance (NMR) spectroscopy for an early detection of cardiometabolic diseases and cardiovascular diseases.

BIOSFER TESLAB, SL supported by CDTI under the PID Programme is implementing the Development of a prediction test for cardiometabolic disease, based on the advanced molecular profile using Nuclear Magnetic Resonance (NMR) spectroscopy and machine learnig techniques.